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Abstract
© 2018 by the authors. Pharmacophore modeling is a widely used strategy for finding new hit
molecules. Since not all protein targets have available 3D structures, ligand-based approaches
are still useful. Currently, there are just a few free ligand-based pharmacophore modeling tools,
and  these  have  a  lot  of  restrictions,  e.g.,  using  a  template  molecule  for  alignment.  We
developed a new approach to 3D pharmacophore representation and matching which does not
require pharmacophore alignment. This representation can be used to quickly find identical
pharmacophores in a given set. Based on this representation, a 3D pharmacophore ligand-based
modeling approach to search for pharmacophores which preferably match active compounds
and do not match inactive ones was developed. The approach searches for 3D pharmacophore
models  starting  from  2D  structures  of  available  active  and  inactive  compounds.  The
implemented approach was successfully applied for several retrospective studies. The results
were  compared  to  a  2D similarity  search,  demonstrating  some of  the  advantages  of  the
developed 3D pharmacophore models. Also, the generated 3D pharmacophore models were
able to match the 3D poses of known ligands from their protein-ligand complexes, confirming
the validity of the models. The developed approach is available as an open-source software tool:
http://www.qsar4u.com/pages/pmapper.php and https://github.com/meddwl/psearch.
http://dx.doi.org/10.3390/molecules23123094
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